Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference49 articles.
1. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997
2. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012
3. Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation;Bejar;J Clin Oncol,2014
4. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes;Bejar;J Clin Oncol,2012
5. Clinical effect of point mutations in myelodysplastic syndromes;Bejar;N Engl J Med,2011
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide;Nature Communications;2024-06-20
2. Single cell profiling of del(5q) MDS unveils its transcriptional landscape and the impact of lenalidomide;2023-10-20
3. Cancer drugs with high repositioning potential for Alzheimer’s disease;Expert Opinion on Emerging Drugs;2023-10-02
4. Lenalidomide improves H2O2‑induced PC12 cell injury by blocking the Notch signaling pathway;Experimental and Therapeutic Medicine;2022-04-29
5. Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series;Frontiers in Oncology;2022-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3